机构:[1]Department of Urology, Guangzhou Institute of Urology, Guangdong Key Laboratory of Urology, The First Affiliated Hospital of GuangzhouMedical University, Guangzhou Medical University, Guangzhou, China,[2]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China,广东省中医院[3]Department of Interventional Radiology, Cancer Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, South China University of Technology, Guangzhou, China,[4]State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China,[5]Guangdong Provincial People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
Prostatitis is a common disease in adult males, with characteristics of a poor treatment response and easy recurrence, which seriously affects the patient's quality of life. The prostate is located deep in the pelvic cavity, and thus a traditional infusion or other treatment methods are unable to easily act directly on the prostate, leading to poor therapeutic effects. Therefore, the development of new diagnostic and treatment strategies has become a research hotspot in the field of prostatitis treatment. In recent years, nanomaterials have been widely used in the diagnosis and treatment of various infectious diseases. Nanotechnology is a promising tool for 1) the accurate diagnosis of diseases; 2) improving the targeting of drug delivery systems; 3) intelligent, controlled drug release; and 4) multimode collaborative treatment, which is expected to be applied in the diagnosis and treatment of prostatitis. Nanotechnology is attracting attention in the diagnosis, prevention and treatment of prostatitis. However, as a new research area, systematic reviews on the application of nanomaterials in the diagnosis and treatment of prostatitis are still lacking. In this mini-review, we will highlight the treatment approaches for and challenges associated with prostatitis and describe the advantages of functional nanoparticles in improving treatment effectiveness and overcoming side effects.
基金:
This work was supported by the National Natural Science
Foundation of China (81573708, 81872437, 82002253),
Guangdong Province Medical Research Fund (No. A2021033),
Scientific research projects of Guangdong Bureau of traditional Chinese Medicine (No.20200513093851). Scientific research
projects in colleges and universities of Guangzhou Education
Bureau (No.201831811), Characteristic innovation projects of
colleges and universities in Guangdong Province
(2019KTSCX140), Guangdong Natural Science Funds for
Distinguished Young Scholar (No. 2015A030306049). The
Specific Research Fund for TCM Science and Technology of
Guangdong Provincial Hospital of Chinese Medicine
(YN2019MJ15), Guangdong Basic and Applied Basic Research
Foundation (2021A1515012573), The Foundation and Applied
Basic Research for Youth of Guangdong Province (No.
2019A1515111108).
第一作者机构:[1]Department of Urology, Guangzhou Institute of Urology, Guangdong Key Laboratory of Urology, The First Affiliated Hospital of GuangzhouMedical University, Guangzhou Medical University, Guangzhou, China,[2]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China,
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Chun-Ping Liu,Zi-De Chen,Zi-Yan Ye,et al.Therapeutic Applications of Functional Nanomaterials for Prostatitis[J].FRONTIERS IN PHARMACOLOGY.2021,12:doi:10.3389/fphar.2021.685465.
APA:
Chun-Ping Liu,Zi-De Chen,Zi-Yan Ye,Dong-Yue He,Yue Dang...&Hong-Xing Liu.(2021).Therapeutic Applications of Functional Nanomaterials for Prostatitis.FRONTIERS IN PHARMACOLOGY,12,
MLA:
Chun-Ping Liu,et al."Therapeutic Applications of Functional Nanomaterials for Prostatitis".FRONTIERS IN PHARMACOLOGY 12.(2021)